Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms

Update on the Aetiopathogenesis of Sjögren Disease: From Interferon Signaling to Epithelial Dysfunction

Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjögren's disease

A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease

Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study

Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis

Impact of Sjögren's disease on quality of sexual life using the Qualisex score

Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study

Association between anti-SSA/SSB antibody profiles and patient-reported outcomes in primary Sjögren's disease

A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjögren Disease Randomized Controlled Trials

Cutaneous Vasculitis in Primary Sjögren Disease

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)

2023 International Rome consensus for the nomenclature of Sjögren disease

Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease

Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data

Precision medicine in Sjögren's disease

Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease

Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study

m(6)A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren's disease

Stability of symptom-based subtypes in Sjogren's disease

Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohort

Macrophage Cell Culture and Characterization by Serum Human AB in Health and Disease

Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death

Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans

Lessons from organoid engineering for rheumatic disease

Immune checkpoint inhibitor-induced joint involvement

Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course

Sicca induced by immune checkpoint inhibitors

Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

Iscalimab 600 mg: justified or excessive? - Authors' reply

Isolated anti-SS-B (La) antibodies: rare occurrence and lack of diagnostic value

Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines

Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland

Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15

Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis

Transient migratory osteoporosis of epiphyseal lower limbs during FLOT chemotherapy for gastric cancer

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Cancer risk associated with abatacept among older individuals with rheumatoid arthritis in the United States

Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE

Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial

Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study

Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum

Treatment of mixed connective tissue disease: A multicenter retrospective study

Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes

JAK Inhibitor Withdrawal Causes a Transient Proinflammatory Cascade: A Potential Mechanism for Major Adverse Cardiac Events

JAK inhibitor withdrawal causes a transient pro-inflammatory cascade: A potential mechanism for major adverse cardiac events

PD1(+) TIGIT(+) CD4(+) T cells predict response to anti-TNF in rheumatoid arthritis and spondyloarthritis

Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

Early-life animal and farming exposures and the risk of rheumatoid arthritis: findings from the E3N French cohort study

Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry

Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study